Long-Term Persistence of Newly Initiated Warfarin Therapy in Chinese Patients With Nonvalvular Atrial Fibrillation
Authors:
- 1 July 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 9 (4) , 380-387
Abstract
Background—: Despite its therapeutic efficacy, warfarin is extremely underused in Chinese patients with nonvalvular atrial fibrillation (AF). Whether the nonpersistence of warfarin treatment contributes to its underuse is not known. The aims of this study were to determine nonpersistence rates of newly started warfarin treatment in Chinese patients with nonvalvular AF and to identify the factors associated with discontinuation of the treatment. Methods and Results—: We identified 1461 patients with nonvalvular AF enrolled in the Chinese Atrial Fibrillation Registry (CAFR) who newly started on warfarin therapy in the period between August 1, 2011, and June 30, 2014. During a follow-up of 426±232 days, 22.1% of patients discontinued warfarin within 3 months, 44.4% within 1 year, and 57.6% within 2 years of initiation of therapy. Patients with no or partial insurance coverage had a higher likelihood to discontinue warfarin than those with full insurance coverage (adjusted hazard ratio 1.65, 95% confidence interval [1.03–2.64]; P =0.038 and 1.66 [1.13–2.42]; P =0.009, respectively). Paroxysmal AF (1.56 [1.28–1.92]; P P =0.0003), and no dyslipidemia (1.34 [1.06–1.70]; P =0.016) were also found to be independent predictors for nonpersistence of warfarin therapy. Conclusions—: Nonpersistence of warfarin treatment becomes a serious problem for stroke prevention in Chinese patients with nonvalvular AF. Our findings can be used to identify patients who require closer attention or to develop better management strategy for oral anticoagulation therapy.Keywords
This publication has 37 references indexed in Scilit:
- Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st centuryInternational Journal of Cardiology, 2013
- Warfarin Discontinuation After Starting Warfarin for Atrial FibrillationCirculation: Cardiovascular Quality and Outcomes, 2010
- Role of Health Insurance in Averting Economic Hardship in Families After Acute Stroke in ChinaStroke, 2009
- Impact of a Prescription Copayment Increase on Lipid-Lowering Medication Adherence in VeteransCirculation, 2009
- Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?Journal of Thrombosis and Haemostasis, 2008
- Epidemiology, Risk Factors for Stroke, and Management of Atrial Fibrillation in ChinaJACC, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland ChinaJournal of Epidemiology, 2008
- Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilizationClinical Therapeutics, 2006
- Adherence to MedicationNew England Journal of Medicine, 2005